Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Emerging Drug Trends
    • Illegal Online Pharmacies
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Emerging Drug Trends
    • Illegal Online Pharmacies
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2026 (9)
  • 2025 (3)

Subject

  • Drug Trafficking (79)
  • Arrests/Convictions - Major (61)
  • Seizures (Drugs/Property) (58)
  • Synthetic drugs (54)
  • Guns/Weapons (46)
  • Major Law Enforcement Operation (35)
  • Fake Pills (25)
  • Prescription Drugs (17)
  • Fentanyl Free America (16)
  • Diversion Division (15)
  • Guilty Plea (15)
  • Task Forces/Task Force Officers (15)
  • Outreach/Drug Prevention (9)
  • Campaigns (8)
  • Counterfeit Pills (8)
  • Fentanyl Awareness (8)
  • OCDETF/Task Force (8)
  • Cartel (7)
  • Overdose (7)
  • Take Back Day (7)
  • Gangs (6)
  • Extraditions (5)
  • Money Laundering (4)
  • Narcoterrorism (4)
  • Homeland Security Task Force (HSTF) (3)
  • International/Foreign Operations (3)
  • One Pill Can Kill (3)
  • Prevention/Education - DEA websites GSAD, JTT etc (3)
  • HIDTA (2)
  • Intergovernmental Affairs (2)
  • Press Conferences (2)
  • Public and Media Affairs - also see Congressional Affairs (2)
  • Asset Forfeiture (1)
  • Critical Incident (1)
  • Forensics: Quality Management System Documents (1)
  • Museum and Visitors Center (1)
  • Other (1)
  • Terrorism (1)
  • Pharmaceuticals/Pharmacists/Physicians (12)

Drug Name

  • Benzodiazepines (1)
  • Fentanyl (1)
  • Hydromorphone (1)
  • Morphine (1)
  • Opioids (1)
  • Oxycodone (1)

Field Division

  • Atlanta (3)
  • Caribe (1)
  • Detroit (1)
  • El Paso (5)
  • Louisville (8)
  • Miami (4)
  • New England (1)
  • New Jersey (2)
  • New York (4)
  • Omaha (4)
  • Phoenix (2)
  • Rocky Mountain (1)
  • San Francisco (7)
  • Seattle (3)
  • Sede (4)
  • St. Louis (8)
  • Tampa (2)
  • Washington, DC (3)
Clear All Results
View Archived Press Releases
12 Results - Showing 1 to 10
PRESS RELEASE

DEA’s National Prescription Drug Take Back Day Safely Removes more than 645,000 Pounds of Unwanted Medications Nationwide

SAN FRANCISCO – On October 24, 2026, the U.S. Drug Enforcement Administration and more than 4,200 law enforcement partners collected 645,636 pounds of unused medications as part of ongoing efforts to prevent drug misuse. This event marked DEA’s 31st National Prescription Drug Take Back Day with 4,212 collection sites nationwide...
PRESS RELEASE

DEA Hosts the 31st National Prescription Drug Take Back Day on Saturday, October 24th

SAN FRANCISCO – The U.S. Drug Enforcement Administration, in collaboration with more than 4,300 law enforcement partners, will host the 31st National Prescription Drug Take Back Day from 10 a.m. to 2 p.m. on Saturday, October 24. More than 4,400 collection sites will be set up across the country to...
PRESS RELEASE

Health Care Fraud Unit Secures Result in Landmark Case Targeting Executives of Fraudulent Mental Health Technology Company That Distributed over 37 Million Pills of Adderall

San Francisco – United States Drug Enforcement Administration (“DEA”) Administrator Terrance Cole, DEA San Francisco Division Special Agent in Charge Bob Beris, DEA Northeast Associate Chief of Operations Frank Tarentino, DEA New York Enforcement Division Special Agent in Charge Farhana Islam, along with our law enforcement partners Homeland Security Investigations...
PRESS RELEASE

Former Albuquerque Dentist Ordered to Pay $320,000 for Violating Controlled Substances and False Claims Acts

ALBUQUERQUE – The DEA and the U.S. Attorney's Office announced today that a federal court has entered a $320,000.00 judgment against a former Albuquerque dentist to resolve allegations that he violated the Controlled Substances Act (CSA) by unlawfully issuing prescriptions after his professional licenses were revoked or expired. William C...
PRESS RELEASE

Stericycle Resolves Criminal and Civil Investigations with over $56 Million Agreement for Long Running Failures in Handling Controlled Substances Bound for Disposal

SACRAMENTO, Calif. — Stericycle Inc., an international waste management company headquartered in Lake Forest, Illinois, has agreed to pay more than $56 million to resolve parallel criminal and civil investigations into its improper handling of controlled substances between 2015 and 2020, U.S. Attorney Eric Grant and Drug Enforcement Administration Special...
PRESS RELEASE

DEA El Paso and Partners Remove 4,796 Pounds of Unused Medications from Communities in West Texas and New Mexico

El Paso, Texas – DEA and its local law enforcement partners collected 4,796 pounds of unused medications during the 30th National Prescription Drug Take Back Day on April 25, 2026. “I had the pleasure of visiting multiple locations in El Paso and saw the overwhelming response from our community,” said...
PRESS RELEASE

United States Files Civil Complaint Against New Mexico Psychologist Alleging Improper Prescribing of Controlled Substances

Note: View the Civil Complaint ALBUQUERQUE – The United States has filed a civil complaint in federal court alleging that a New Mexico psychologist unlawfully prescribed controlled substances without a legitimate medical purpose, in violation of the Controlled Substances Act. In a complaint filed in federal court, the United States...
PRESS RELEASE

Sutter Facilities Agree to Pay $3.2 Million to Resolve Alleged Controlled Substances Act Violations

SACRAMENTO, Calif. — Sutter Medical Center, Sacramento, and Sutter Fairfield Surgery Center have agreed to pay $3.2 million to resolve allegations that they failed to effectively guard against theft and diversion of controlled substances, U.S. Attorney Eric Grant and Drug Enforcement Administration Special Agent in Charge Bob P. Beris announced...
PRESS RELEASE

El Paso Doctor Enters $200,000 Settlement Following State and Federal Fraud Allegations

EL PASO, Texas – Dr. Brian August, located in El Paso, has agreed to pay $200,000 to resolve allegations that he violated the Controlled Substances Act, the False Claims Act, and the Texas Health Care Program Fraud Prevention Act. The allegations involved the issuance of 255 controlled substance prescriptions to...
PRESS RELEASE

Southern New Mexico Medical Spa Operator Settles Allegations of Controlled-Substance Recordkeeping Violations

Note: View the Settlement Agreement ALBUQUERQUE – The United States has reached a civil settlement with Luis Carlos Cordova, operator of Limitless Aesthetics and Healthcare in Santa Teresa, New Mexico, to resolve allegations that he failed to meet federal controlled-substance recordkeeping requirements under the Controlled Substances Act. According to the...

Paginación

  • Current page 1
  • Page 2
  • Siguiente
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster